Adrenal atrophy
For patient information, click here
|
Adrenal atrophy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Adrenal atrophy On the Web |
|
American Roentgen Ray Society Images of Adrenal atrophy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Adrenal atrophy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy=
Adrenal atrophy is the irreversible damage to the adrenal tissue, due to direct trauma or the secondary causes. As a result, treatment of the adrenal atrophy is a conservative treatment. For adrenal crisis:
- Intravenous fluids
- Intravenous steroids
The cortisol deficiency is treated by supplementing with cortisol, prednisolone, prednisone, methylprednisolone, and dexamethasone. The mineralocorticoid insufficiency is also cured by the fludrocortisone.
Primary Prevention
Primary prevention of the adrenal atrophy consists of avoiding overuse of exogenous corticosteroid drugs.
Secondary Prevention
The secondary prevention of the adrenal atrophy is also known as early diagnosis of any steroid or mineralocorticoid deficiency in the body, as discussed at the causes section, and its early appropriate treatments.[1][2]
Case Studies
- ↑ Hahner S, Allolio B (April 2009). "Therapeutic management of adrenal insufficiency". Best Pract Res Clin Endocrinol Metab. 23 (2): 167–79. doi:10.1016/j.beem.2008.09.009. PMID 19500761.
- ↑ Barnett AH, Espiner EA, Donald RA (November 1982). "Patients presenting with Addison's disease need not be pigmented". Postgrad Med J. 58 (685): 690–2. doi:10.1136/pgmj.58.685.690. PMC 2426562. PMID 7170268.